Cargando…
Alpelisib-Induced Diabetic Ketoacidosis: A Case Report and Review of Literature
OBJECTIVE: To report the first case of diabetic ketoacidosis (DKA) and its management in a patient with diet-controlled prediabetes and metastatic breast cancer treated with alpelisib, a PI3K (phosphatidylinosiotol-3-kinase) inhibitor. METHODS: Literature on the topic is reviewed. The case is that o...
Autores principales: | Carrillo, Maritza, Rodriguez, Renil M., Walsh, Christopher L., Mcgarvey, Megan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association of Clinical Endocrinology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053625/ https://www.ncbi.nlm.nih.gov/pubmed/34095470 http://dx.doi.org/10.1016/j.aace.2020.11.028 |
Ejemplares similares
-
Alpelisib-Induced Diabetic Ketoacidosis- A Case Report
por: Rodriguez, Lisette Patricia, et al.
Publicado: (2021) -
Alpelisib-Induced Diabetic Ketoacidosis
por: Espinosa, Luis Borges, et al.
Publicado: (2021) -
Alpelisib-Induced Diabetic Ketoacidosis
por: Nguyen, Paul, et al.
Publicado: (2021) -
Diabetic Ketoacidosis With Alpelisib
por: Jeun, Rebecca, et al.
Publicado: (2021) -
Alpelisib-Induced Diabetic Ketoacidosis in a Non-diabetic Patient
por: Fugere, Tyler, et al.
Publicado: (2021)